Skip to main content
Molecule libraryReference fact sheet

GHK-Cu

Why this molecule?

Naturally present in the body, GHK-Cu has been studied for several decades for its links with tissue repair, the extracellular matrix and certain regeneration processes.

Repair & Recovery ~6 min readAlso known asCopper glycyl-L-histidyl-L-lysineCopper tripeptide-1
  • Research Use Only
  • Molecule under study
  • Living document

View the corresponding reference in the shop

Research state
Current research state
Used in topical cosmetics; laboratory and animal research is ongoing, while evidence for effects throughout the human body remains limited.
Current clinical phase
Targeted clinical studies of skin and wound healing; no broad drug-development programme
Last update
21 July 2026 · Reference fact sheet v1.0
Living document
Updated regularly as research progresses.
01 · Reference points

What is GHK-Cu?

GHK is a short peptide made of three amino acids: glycine, histidine and lysine. Loren Pickart first isolated it from human blood plasma in 1973.

Its concentration in blood plasma has been reported to fall with age (roughly 200 ng/mL at 20 versus 80 ng/mL around 60). This has prompted questions about its role in tissue repair, not proved a benefit from adding it.

When GHK binds a copper (II) ion, it forms GHK-Cu. This copper-bound form is the one most often studied for biological effects.

02 · Reference points

Names you may come across

This molecule may appear under several names in the scientific, clinical or technical literature. Here are the main designations you may come across.

GHK-Cu

The usual name in scientific and cosmetic literature.

Tripeptide-1

The INCI ingredient name used on cosmetic labels.

Copper Peptide

A common commercial name, especially for products applied to the skin.

03 · Made simple

Understanding it simply

Three simple points to understand GHK-Cu.

1

A small peptide with wide-ranging effects in the lab

Despite having only three amino acids, GHK has been shown to affect the activity of many genes in laboratory studies of skin and connective-tissue cells.

2

A link to copper

Several enzymes in the skin need copper to work. Researchers are studying whether GHK-Cu helps carry copper to tissues.

3

A history in cosmetics

GHK-Cu has appeared in skin-applied cosmetic products since the 1980s. This is its best-documented area of use.

04 · Scientific honesty

What research shows today

Science advances step by step. We clearly distinguish what is firmly established from what remains under study.

Current state of knowledge
  • First isolated from human blood plasma by Loren Pickart in 1973. — established
  • GHK's strong ability to bind copper (II) is documented. — established
  • Laboratory studies show effects on the production of collagen, elastin and other support materials by fibroblasts, the cells that help maintain tissue. — established
  • Changes in gene activity have been described in several studies, including Connectivity Map research in 2010. — established
  • Effects throughout the human body after injection have not been well studied in randomized clinical trials. — ongoing

Known since 1973 and widely studied in cells and animals. Topical cosmetic use is documented; effects throughout the body remain a research question.

What the research shows

  • In cell studies, GHK-Cu affects fibroblasts and their production of collagen, elastin and other tissue-supporting materials.
  • Improved wound healing has been observed in several animal models, including rodents, pigs and rabbits.
  • Antioxidant and anti-inflammatory effects have been reported in cell studies.
  • Topical cosmetic use is established and was generally well tolerated in the published studies.

What still remains to be studied

  • The size of any effects throughout the human body after injection: few randomized clinical trials are available.
  • How the body absorbs, distributes and clears it is not yet fully understood.
  • The long-term effects of repeated external exposure in humans have not been established.
05 · Three reading levels

What we know today

Not all information carries the same weight of evidence. We therefore present it across three clearly distinct levels, from the most solid to the most indicative.

What scientific publications show

Scientific evidence
  • Preclinical studies suggest a role in tissue repair, including wound healing and the material supporting cells.
  • Cosmetic studies report measurable changes in skin quality after repeated application to the skin.
  • Gene-expression studies suggest that GHK-Cu may affect several processes inside cells.

What some professionals report

Documented
  • Dermatologists and cosmetic formulators have used GHK-Cu as a documented skin-care ingredient for decades.
  • Researchers note that it does not replace medical treatment for complex wounds.

What the community reports

Field observations
  • Personal accounts mostly concern skin-applied products, such as perceived changes in skin appearance or scars.
  • Individual observations cannot replace controlled clinical evidence.

The evidence is uneven: substantial for laboratory and topical cosmetic research, much more limited for injected use in humans.

06 · The mechanism

How does GHK-Cu work?

Researchers study GHK-Cu both as a biological signal and as a carrier of copper.

Fibroblasts
Possible effects on the production of collagen, elastin and other tissue-supporting materials.
Copper (II)
Possible transport of copper to tissues, where some enzymes use it.
Inflammation pathways
Changes in the activity of genes linked to inflammation in gene-expression studies.
Repair pathways
Changes in patterns of gene activity linked to wound healing and tissue remodelling.

These mechanisms have mostly been studied in cells and animals. We do not yet know how closely the findings apply to humans.

07 · The scientific journey

Clinical trials timeline

A molecule under study progresses step by step. Here, simply, is where the research currently stands.

Discovery of the tripeptideBiochemical characterizationPreclinical skin and wound studiesTopical cosmetic useClinical studies of effects throughout the body
  1. Discovery· 1973Completed

    Isolation by Loren Pickart

    GHK is identified in human blood plasma during research on liver cell function.

  2. Research· 1980sCompleted

    Characterization of the GHK-Cu complex

    Studies describe how GHK binds copper and interacts with fibroblasts, cells involved in tissue repair.

  3. Cosmetic· 1990sCompleted

    Topical use in cosmetics

    GHK-Cu is included in skin-care formulations, with generally favourable tolerability reported.

  4. Research· 2010Completed

    BMC Genomics gene-expression study

    Pickart and colleagues publish research describing broad changes in gene activity using Connectivity Map data.

  5. Ongoing· CurrentlyOngoing

    Targeted preclinical and clinical research

    Research continues into wound healing, skin and other targeted applications; randomized trials of effects throughout the body remain scarce.

08 · Documented proof

Available analyses

Analytical documents provided by suppliers and published for GHK-Cu, available in the Analysis Library. They document batch traceability and are not an independent analysis performed by PHL.

Open the analysis library
09 · Reference points

Frequently asked questions

Is GHK-Cu a medicine?

No. It is used as a cosmetic ingredient in many countries and remains a subject of research. PHL does not suggest therapeutic use.

Why are some formulations blue or violet?

The colour comes from the copper (II)–peptide complex in solution.

Do skin-applied and injected GHK-Cu have the same effects?

We do not know. Topical use has more evidence, while human evidence for injected use is limited. Findings from one route cannot simply be applied to the other.

What side effects have been described?

Topical products are generally well tolerated in published studies, although irritation can occur. Long-term safety of exposure throughout the body has not been established.

Does GHK really decrease with age?

Several studies have measured a gradual decline in blood-plasma GHK with age. What that decline means for health remains debated.

10 · Bibliography

Scientific publications

Selected GHK-Cu publications covering basic science, preclinical studies and skin applications. This reading list may be updated as research develops.

Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver

Pickart L., Thaler M. M. · Nature New Biology · 1973

Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+

Maquart F. X. et al. · FEBS Letters · 1993

11 · The vocabulary

Glossary

Tripeptide
A chain of three amino acids, the building blocks of proteins.
Fibroblast
A connective-tissue cell that makes collagen and other material supporting nearby cells.
Extracellular matrix
A network of proteins, including collagen and elastin, that supports cells.
Chelation
When a molecule binds a metal ion, in this case copper.
Transcriptomics
The study of messenger RNA, which helps show which genes are active in a cell.
INCI
The international naming system for cosmetic ingredients.
The PHL ecosystem

Continue your discovery

Read next

Sheets that are thematically close. These links serve reading and discovery — they suggest no combined use.

Reference fact sheet — version 1.0, updated on 21 July 2026. The full regulatory and scientific framework is gathered in the “Important information” box at the top of the fact sheet.

Explore the fundamentals related to this goal

This general content is independent of the molecule and is neither a use strategy nor a protocol.

Published analyses (1)

View GHK-Cu analyses →